Browse by Subject histone deacetylase
Showing results 1 to 6 of 6
| Cancer reversion, a renewed challenge in systems biology Cho, Kwang-Hyun; Lee, Soobeom; Kim, Dongsan; Shin, Dongkwan; Joo, Jae Il; Park, Sang-Min, Current Opinion in Systems Biology, v.2, pp.49 - 58, 2017-04 |
| Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells Lee, Ji-Hyun; Kim, Kyung-Ah; Kwon, Kang-Beom; Kim, Eun-Kyung; Lee, Young-Rae; Song, Mi-Young; Koo, Jeung-Hyun; et al, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, v.20, no.1, pp.59 - 64, 2007-07 |
| Histone deacetylases, HDAC1 and HSIR2, act as a negative regulator of ageing through p53 in human gingival fibroblast Kim, MM; Yoon, SO; Cho, YS; Chung, An Sik, MECHANISMS OF AGEING AND DEVELOPMENT, v.125, no.5, pp.351 - 357, 2004-05 |
| Histone deacetylases, HDAC1 and HSIR2, act as a negative regulator of aging in human gingival fibroblast via p53 and Sp1 transcription factors = 히스톤 탈아세틸화 효소인 HDAC1과 HSIR2는 p53과 Sp1전사인자에 영향을 미쳐 치은섬유아세포에서 노화억제 조절자로 작용한link Kim, Moon-Moo; 김문무; et al, 한국과학기술원, 2003 |
| Modification of cap group in delta-lactam-based histone deacetylase (HDAC) inhibitors Kim, HM; Hong, SH; Kim, MS; Lee, CW; Kang, JS; Lee, K; Park, SK; et al, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.17, no.72, pp.6234 - 6238, 2007-11 |
| Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel delta-lactam-based histone deacetylase (HDAC) inhibitors Kim, HM; Lee, K; Park, BW; Ryu, DK; Kim, K; Lee, CW; Park, SK; et al, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.16, no.15, pp.4068 - 4070, 2006-08 |
Discover
Type
Open Access
Date issued
- 30,970 2020 - 2024
- 100,006 2010 - 2019
- 75,681 2000 - 2009
- 44,727 1990 - 1999
- 14,360 1980 - 1989
- 62 1964 - 1969